A Dark Vector Cognition product

Item 16. FORM 10-K SUMMARY

5K characters. Original on sec.gov ·

Item 16. FORM 10-K SUMMARY

The 2 tables in Item 16. FORM 10-K SUMMARY as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 10th day of February, 2022.

Huntington Ingalls Industries, Inc.
/s/ C. Michael Petters
C. Michael Petters
President and Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
SignatureTitleDate
/s/ C. Michael PettersPresident, Chief Executive Officer and Director
C. Michael Petters(Principal Executive Officer)February 10, 2022
/s/ Thomas E. StiehleExecutive Vice President and
Thomas E. StiehleChief Financial Officer
(Principal Financial Officer)February 10, 2022
/s/ Nicolas SchuckCorporate Vice President, Controller
Nicolas Schuckand Chief Accounting Officer
(Principal Accounting Officer)February 10, 2022
/s/ Kirkland H. Donald
Kirkland H. DonaldChairmanFebruary 10, 2022
/s/ Philip M. Bilden
Philip M. BildenDirectorFebruary 10, 2022
/s/ Augustus L. Collins
Augustus L. CollinsDirectorFebruary 10, 2022
/s/ Victoria D. Harker
Victoria D. HarkerDirectorFebruary 10, 2022
/s/ Frank R. Jimenez
Frank R. JimenezDirectorFebruary 10, 2022
/s/ Anastasia D. Kelly
Anastasia D. KellyDirectorFebruary 10, 2022
/s/ Tracy B. McKibben
Tracy B. McKibbenDirectorFebruary 10, 2022
/s/ Stephanie L. O'Sullivan
Stephanie L. O'SullivanDirectorFebruary 10, 2022
/s/ Thomas C. Schievelbein
Thomas C. SchievelbeinDirectorFebruary 10, 2022
/s/ John K. Welch
John K. WelchDirectorFebruary 10, 2022
/s/ Stephen R. Wilson
Stephen R. WilsonDirectorFebruary 10, 2022

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES